{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:45:14Z","timestamp":1792734314489,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T00:00:00Z","timestamp":1045094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s00213-002-1340-7","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T13:22:16Z","timestamp":1478956936000},"page":"264-270","source":"Crossref","is-referenced-by-count":92,"title":["Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma"],"prefix":"10.1007","volume":"166","author":[{"given":"Nora D.","family":"Volkow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Jack","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna S.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. John","family":"Gatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi R.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,13]]},"reference":[{"key":"1340_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1176\/ajp.131.7.817","volume":"131","author":"Angrist","year":"1974","unstructured":"Angrist B, Lee HK, Gershon S (1974) The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry 131:817\u2013819","journal-title":"Am J Psychiatry"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00002826-200105000-00004","volume":"24","author":"Angrist","year":"2001","unstructured":"Angrist B, Sanfilipo M, Wolkin A (2001) Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol. Clin Neuropharmacol 24:139\u2013144","journal-title":"Clin Neuropharmacol"},{"key":"1340_CR3","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1001\/jama.1976.03270260026021","volume":"236","author":"Ballard","year":"1976","unstructured":"Ballard JE, Boileau RA, Sleator EK, Massey BH, Sprague RL (1976) Cardiovascular responses of hyperactive children to methylphenidate. JAMA 236:2870\u20132874","journal-title":"JAMA"},{"key":"1340_CR4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569\u20132574","journal-title":"Proc Natl Acad Sci USA"},{"key":"1340_CR5","first-page":"473","volume":"45","author":"Brown","year":"1984","unstructured":"Brown RT, Wynne ME, Slimmer LW (1984) Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 45:473\u2013476","journal-title":"J Clin Psychiatry"},{"key":"1340_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archpsyc.1987.01800150110013","volume":"44","author":"Chiarello","year":"1987","unstructured":"Chiarello RJ, Cole JO (1987) The use of psychostimulants in general psychiatry. A reconsideration. Arch Gen Psychiatry 44:266\u2013295","journal-title":"Arch Gen Psychiatry"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0306-4522(97)00157-7","volume":"81","author":"Cornish","year":"1997","unstructured":"Cornish JL, Wilks DP, Van den Buuse M (1997) A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats. Neuroscience 81:69\u201378","journal-title":"Neuroscience"},{"key":"1340_CR8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.890130407","volume":"13","author":"Dewey","year":"1993","unstructured":"Dewey SL, Smith GS, Logan J, Brodie JD, Fowler JS, Wolf AP (1993) Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350\u2013356","journal-title":"Synapse"},{"key":"1340_CR9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00004583-200105000-00011","volume":"40","author":"Findling","year":"2001","unstructured":"Findling RL, Short EJ, Manos MJ (2001) Short-term cardiovascular effects of methylphenidate and adderall. J Am Acad Child Adolesc Psychiatry 40:525\u2013529","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1340_CR10","unstructured":"Ganong WF (2001) Review of medical physiology, 12th edn. McGraw-Hill, New York"},{"key":"1340_CR11","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/00004583-200202001-00003","volume":"41","author":"Greenhill","year":"2002","unstructured":"Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S (2002) American academy of child and adolescent psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26S\u201349S","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/0024-3205(84)90568-X","volume":"34","author":"Joyce","year":"1984","unstructured":"Joyce PR, Nicholls MG, Donald RA (1984) Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects. Life Sci 34:1707\u20131711","journal-title":"Life Sci"},{"key":"1340_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674378402900112","volume":"29","author":"Kaufman","year":"1984","unstructured":"Kaufman MW, Cassem NH, Murray GB, Jenike M (1984) Use of psychostimulants in medically ill patients with neurological disease and major depression. Can J Psychiatry 29:46\u201349","journal-title":"Can J Psychiatry"},{"key":"1340_CR14","unstructured":"Kirk RE (1990) Statistics: an introduction. Holt, Rinehart, and Winston, Fort Worth"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00008480-200204000-00013","volume":"14","author":"Klein-Schwartz","year":"2002","unstructured":"Klein-Schwartz W (2002) Abuse and toxicity of methylphenidate. Curr Opin Pediatr 14:219\u2013223","journal-title":"Curr Opin Pediatr"},{"key":"1340_CR16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","volume":"68","author":"Kuczenski","year":"1997","unstructured":"Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. Neurochemistry 68:2032\u20132037","journal-title":"Neurochemistry"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-2999(94)00699-8","volume":"273","author":"Kujacic","year":"1995","unstructured":"Kujacic M, Hansson LO, Carlsson A (1995) Acute dopaminergic influence on plasma adrenaline levels in the rat. Eur J Pharmacol 273:247\u2013257","journal-title":"Eur J Pharmacol"},{"key":"1340_CR18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"Laruelle","year":"2000","unstructured":"Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423\u2013451","journal-title":"J Cereb Blood Flow Metab"},{"key":"1340_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","volume":"71","author":"Le","year":"1991","unstructured":"Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155\u2013234","journal-title":"Physiol Rev"},{"key":"1340_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/sleep\/24.5.603","volume":"24","author":"Littner","year":"2001","unstructured":"Littner M, Johnson SF, McCall WV, Anderson WM, Davila D, Hartse SK, Kushida CA, Wise MS, Hirshkowitz M, Woodson BT (2001) Standards of practice committee. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep 24:451\u2013466","journal-title":"Sleep"},{"key":"1340_CR21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer D, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, Christman DR (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(1)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747","journal-title":"J Cereb Blood Flow Metab"},{"key":"1340_CR22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/jcbfm.1994.132","volume":"14","author":"Logan","year":"1994","unstructured":"Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemann R, Vitkun S (1994) Effects of blood flow on [11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995\u20131010","journal-title":"J Cereb Blood Flow Metab"},{"key":"1340_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10641969709080813","volume":"19","author":"Mannelli","year":"1997","unstructured":"Mannelli M, Lazzeri C, Ianni L, La Villa G, Pupilli C, Bellini F, Serio M, Franchi F (1997) Dopamine and sympathoadrenal activity in man. Clin Exp Hypertens 19:163\u2013179","journal-title":"Clin Exp Hypertens"},{"key":"1340_CR24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.1991.00400040119027","volume":"151","author":"Parran","year":"1991","unstructured":"Parran TV, Jasinski DR (1991) Intravenous methylphenidate abuse: prototype for prescription drug abuse. Arch Intern Med 151:781\u2013783","journal-title":"Arch Intern Med"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1200\/JCO.20.1.335","volume":"20","author":"Rozans","year":"2002","unstructured":"Rozans M, Dreisbach A, Lertora JJ, Kahn MJ (2002) Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 20:335\u2013339","journal-title":"J Clin Oncol"},{"key":"1340_CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1037\/1064-1297.9.1.59","volume":"9","author":"Rush","year":"2001","unstructured":"Rush CR, Baker RW (2001) Behavioral pharmacological similarities betwen methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9:59\u201373","journal-title":"Exp Clin Psychopharmacol"},{"key":"1340_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1124\/jpet.300.1.180","volume":"300","author":"Schindler","year":"2002","unstructured":"Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR (2002) Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys. J Pharmacol Exp Ther 300:180\u2013187","journal-title":"J Pharmacol Exp Ther"},{"key":"1340_CR27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.890030113","volume":"3","author":"Seeman","year":"1989","unstructured":"Seeman P, Guan HC, Niznik HB (1989) Endogenous dopamine lowers the dopamine D2 receptor density as measured by 3H raclopride: implications for positron emission tomography of the human brain. Synapse 3:96\u201397","journal-title":"Synapse"},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0278-5846(91)90083-D","volume":"Psychiatry15","author":"Srinivas","year":"1991","unstructured":"Srinivas NR, Hubbard JW, Quinn D, Korchinski ED, Midha K (1991) Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans. Prog Neuropsychopharmacol Biol Psychiatry15:213\u2013220","journal-title":"Prog Neuropsychopharmacol Biol"},{"key":"1340_CR29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1345\/aph.1A367","volume":"36","author":"Stowe","year":"2002","unstructured":"Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG (2002) 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. Ann Pharmacother 36:1142\u20131149","journal-title":"Ann Pharmacother"},{"key":"1340_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/002221949102400406","volume":"24","author":"Swanson","year":"1991","unstructured":"Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G (1991) Effects of stimulant medication on learning in children with ADHD. J Learn Disabil 24:219\u2013230","journal-title":"J Learn Disabil"},{"key":"1340_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0091-3057(95)02145-0","volume":"54","author":"Tella","year":"1996","unstructured":"Tella SR (1996) Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence. Pharmacol Biochem Behav 54:343\u2013354","journal-title":"Pharmacol Biochem Behav"},{"key":"1340_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0091-3057(97)00448-6","volume":"59","author":"Tella","year":"1998","unstructured":"Tella SR, Goldberg SR (1998) Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav 59:305\u2013312","journal-title":"Pharmacol Biochem Behav"},{"key":"1340_CR33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1440-1681.1997.tb02129.x","volume":"24","author":"van","year":"1997","unstructured":"van den Buuse M (1997) Pressor responses to brain dopaminergic stimulation. Clin Exp Pharmacol Physiol 24:764\u2013769","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1340_CR34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1440-1681.1998.tb02273.x","volume":"25","author":"van","year":"1998","unstructured":"van den Buuse M (1998) Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin Exp Pharmacol Physiol 25:661\u2013668","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1340_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bjp.0702982","volume":"129","author":"van","year":"2000","unstructured":"van den Buuse M, Catanzariti R (2000) Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats. Br J Pharmacol 129:29\u201336","journal-title":"Br J Pharmacol"},{"key":"1340_CR36","first-page":"609","volume":"34","author":"Volkow","year":"1993","unstructured":"Volkow ND, Fowler JS, Wang G-J, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf AP (1993) Reproducibility of repeated measures of 11C raclopride binding in the human brain. J Nucl Med 34:609\u2013613","journal-title":"J Nucl Med"},{"key":"1340_CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/syn.890160402","volume":"16","author":"Volkow","year":"1994","unstructured":"Volkow ND, Wang G-J, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, Mac Gregor R, Burr G, Cooper T, Wolf AP (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255\u2013262","journal-title":"Synapse"},{"key":"1340_CR38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archpsyc.1995.03950180042006","volume":"52","author":"Volkow","year":"1995","unstructured":"Volkow ND, Ding Y-S, Fowler JS, Wang GJ, Logan J, Gatley SJ, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456\u2013463","journal-title":"Arch Gen Psychiatry"},{"key":"1340_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","volume":"291","author":"Volkow","year":"1999","unstructured":"Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann RJ, Pappas N (1999) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharmacol Exp Ther 291:409\u2013415","journal-title":"J Pharmacol Exp Ther"},{"key":"1340_CR40","first-page":"1285","volume":"40","author":"Wang","year":"1999","unstructured":"Wang G-J, Volkow ND, Fowler JS, Logan J, Pappas NR, Natusil N, Wong CT, Hitzemann RJ (1999) Reproducibility of repeated measures of endogenous dopamine competition with [C-11]raclopride in the human brain. J Nucl Med 40:1285\u20131291","journal-title":"J Nucl Med"},{"key":"1340_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/108705470100500401","volume":"5","author":"Wilens","year":"2002","unstructured":"Wilens TE, Spencer TJ, Biederman J (2002) A review of the pharmacotherapy of adults with attention-deficit\/hyperactivity disorder. J Atten Disord 5:189\u2013202","journal-title":"J Atten Disord"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-002-1340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-002-1340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-002-1340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-002-1340-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T08:19:25Z","timestamp":1749716365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-002-1340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,13]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s00213-002-1340-7","relation":{},"ISSN":["0033-3158"],"issn-type":[{"value":"0033-3158","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,13]]}}}